Overjet’s device detects instances of periapical radiolucency on radiographs.
This is Overjet’s fifth FDA clearance, according to a Nov. 9 news release. The clearance makes the company the first and only dental AI provider capable of detecting and outlining instances of periapical radiolucency on radiographs for patients ages 12 and older.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
